Viewing Study NCT07126561

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:05 PM
Ignite Modification Date: 2026-01-31 @ 10:51 PM
Study NCT ID: NCT07126561
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-17
First Post: 2025-08-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers
Sponsor: University of Chicago
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2 Positive Newly Diagnosed Metastatic Esophageal, Gastric, GEJ Cancer Patients … View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2 View
None TRASTUZUMAB View
None DERUXTECAN View
None METASTATIC View
None CANCER View
None ESOPHAGEAL View
None GASTRIC View
None GEJ View